Immunovia announces annual shareholder meeting notice

  • Immunovia scheduled annual general meeting in Lund on May 13, 2026.
  • Shareholders set to vote on adopting 2025 financial statements, profit allocation with no dividend, discharge of board members and CEO.
  • Meeting to decide board and auditor fees, re-election of six board members, re-election of Peter Høngaard Andersen as chair.
  • Grant Thornton Sweden proposed as auditor, with Therése Utengen as auditor in charge.
  • Agenda includes mandate to issue shares, convertibles, warrants up to 20% of shares outstanding, option programs tied to up to 28,322,818 shares for management and key staff plus up to 7,080,702 shares for board members.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunovia AB published the original content used to generate this news brief on April 13, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.